Association between the rs1050450 glutathione peroxidase-1 (C > T) gene variant and peripheral neuropathy in two independent samples of subjects with diabetes mellitus

Thomas, 1999, Diabetic peripheral neuropathies: their cost to patient and society and the value of knowledge of risk factors for development of interventions, Eur Neurol, 1, 35, 10.1159/000052078 Boulton, 1998, Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy, Diabet Med, 15, 508, 10.1002/(SICI)1096-9136(199806)15:6<508::AID-DIA613>3.0.CO;2-L Group TDCaCTR, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 Bedlack, 2003, APOE genotype is a risk factor for neuropathy severity in diabetic patients, Neurology, 60, 1022, 10.1212/01.WNL.0000056689.50682.94 Stephens, 2006, Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males, Clin Chem, 52, 446, 10.1373/clinchem.2005.060194 Kopprasch, 2002, In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance, Diabetes, 51, 3102, 10.2337/diabetes.51.10.3102 Beckett, 2005, Selenium and endocrine systems, J Endocrinol, 184, 455, 10.1677/joe.1.05971 Forgione, 2002, Cellular glutathione peroxidase deficiency and endothelial dysfunction, Am J Physiol Heart Circ Physiol, 282, H1255, 10.1152/ajpheart.00598.2001 Espinola-Klein, 2007, Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosis, Am J Cardiol, 99, 808, 10.1016/j.amjcard.2006.10.041 Blankenberg, 2003, Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease, N Engl J Med, 349, 1605, 10.1056/NEJMoa030535 Sun, 2009, Changes of lipid peroxidation in carbon disulfide-treated rat nerve tissues and serum, Chem Biol Interact, 179, 110, 10.1016/j.cbi.2008.11.014 Kishi, 2000, Gene expression of antioxidant enzymes in experimental diabetic neuropathy, J Peripher Nerv Syst, 5, 11, 10.1046/j.1529-8027.2000.00144.x Martinez-Blasco, 1998, Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved, Biofactors, 8, 41, 10.1002/biof.5520080108 Rosenblat, 1998, Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: in vitro and in vivo studies, Free Radic Biol Med, 24, 305, 10.1016/S0891-5849(97)00231-1 Guo, 2001, Changes in expression of antioxidant enzymes affect cell-mediated LDL oxidation and oxidized LDL-induced apoptosis in mouse aortic cells, Arterioscler Thromb Vasc Biol, 21, 1131, 10.1161/hq0701.092092 Ravn-Haren, 2006, Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study, Carcinogenesis, 27, 820, 10.1093/carcin/bgi267 Hamanishi, 2004, Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients, Diabetes, 53, 2455, 10.2337/diabetes.53.9.2455 Tang, 2008, Genetic variant in glutathione peroxidase 1 gene is associated with an increased risk of coronary artery disease in a Chinese population, Clin Chim Acta, 395, 89, 10.1016/j.cca.2008.05.013 Kuzuya, 2008, Glutathione peroxidase 1 Pro198Leu variant contributes to the metabolic syndrome in men in a large Japanese cohort, Am J Clin Nutr, 87, 1939, 10.1093/ajcn/87.6.1939 Mir, 2009, Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity, Ann Oncol, 20, 736, 10.1093/annonc/mdn698 Chistiakov, 2006, The 262T > C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients, Diabete Metab, 32, 63, 10.1016/S1262-3636(07)70248-3 Dhamrait, 2004, Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2, Eur Heart J, 25, 468, 10.1016/j.ehj.2004.01.007 Stephens, 2006, A common variant in the ACE gene is associated with peripheral neuropathy in women with type 2 diabetes mellitus, J Diabet Complications, 20, 317, 10.1016/j.jdiacomp.2005.07.010 Alberti, 1998, New diagnostic criteria and classification of diabetes – again?, Diabet Med, 15, 535, 10.1002/(SICI)1096-9136(199807)15:7<535::AID-DIA670>3.0.CO;2-Q American Diabetes Association, 1998, Report and recommendations of the San Antonio conference on diabetic neuropathy, Diabetes Care, 11, 592, 10.2337/diacare.11.7.592 Sampson, 2002, Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes, Diabetes Care, 25, 537, 10.2337/diacare.25.3.537 Scheffer, 2003, Associations of LDL size with in vitro oxidizability and plasma levels of in vivo oxidized LDL in Type 2 diabetic patients, Diabet Med, 20, 563, 10.1046/j.1464-5491.2003.00975.x Rothman, 1990, No adjustments are needed for multiple comparisons, Epidemiology, 1, 43, 10.1097/00001648-199001000-00010 Raaschou-Nielsen, 2007, GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer, Cancer Lett, 247, 293, 10.1016/j.canlet.2006.05.006 Steinbrecher, 1984, Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids, Proc Natl Acad Sci U S A, 81, 3883, 10.1073/pnas.81.12.3883 Said, 2003, Inflammatory vasculopathy in multifocal diabetic neuropathy, Brain, 126, 376, 10.1093/brain/awg029 Tsuzura, 2004, Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes, Metabolism, 53, 297, 10.1016/j.metabol.2003.10.009 Sobal, 2000, Influence of acetylsalicylic acid on oxidation of native and glycated low-density lipoprotein, Life Sci, 66, 1987, 10.1016/S0024-3205(00)00524-5 Galland, 2006, Effect of insulin treatment on plasma oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients, Diabete Metab, 32, 625, 10.1016/S1262-3636(07)70318-X Risch, 2000, Searching for genetic determinants in the new millennium, Nature, 405, 847, 10.1038/35015718